← 返回

设计一种模拟 NK 细胞的人工系统以靶向肿瘤细胞

英文原题:Design of an artificial natural killer cell mimicking system to target tumour cells.

查看英文原题

Design of an artificial natural killer cell mimicking system to target tumour cells.

PubMed 2025/09/27(内容时间) J Tissue Eng Q1 · IF 10.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

NK细胞模拟物是细胞膜与模板的组装体,分别复制了仿生特征和理化性质。为开发这一靶向药物递送系统,采用油包水乳液法制备了明胶微球(cG),并通过DMTMM交联进行增强,使其表现出可调的杨氏模量,这是细胞-材料相互作用的关键参数。随后,这些微球被来自人NK细胞系KHYG-1的膜包覆,形成仿生NK细胞模拟物(cGCM),将理化控制与仿生功能相结合。这些工程化的cGCM无毒、无炎症,并且在与分化的THP-1细胞孵育时能够将巨噬细胞摄取降低约10%。体外研究表明,在乳腺癌细胞(MDA-MB-231)2D培养、肝癌(HepG2)和结肠癌(HT-29)细胞模型的3D球体以及斑马鱼乳腺癌异种移植(MDA-MB-231)模型中,cGCM与癌细胞具有显著的相互作用/邻近性。cGCM还在Kdrl:EGFP Spil:Ds Red斑马鱼模型中逃避了巨噬细胞检测。

此外,在一项初步评估中,使用cGCM负载并释放唾液酸转移酶抑制剂(STI,3Fax-Peracetyl Neu5Ac)显著降低了MDA-MB-231细胞2D培养中的α-2,6唾液酸化,证明该STI在抑制唾液酸化方面功能完好。通过将仿生膜与机械可调的明胶基载体相结合,我们的系统展示了一个多功能的免疫模拟平台,与组织工程、肿瘤建模、免疫调节和药物递送相关。这些发现为癌症研究和免疫工程中的未来治疗策略提供了有前景的基础。

展开英文摘要原文

NK cell mimics are assemblies of a cell membrane and a template that replicate biomimetic features and physicochemical properties, respectively. To develop this targeted drug delivery system, gelatin microspheres (cG) were fabricated using a water-in-oil emulsion and reinforced via DMTMM cross-linking to exhibit tunable Young's modulus, a critical parameter for cell-material interactions. These microspheres were subsequently coated with membranes derived from the human NK cell line KHYG-1 to form biomimetic NK cell mimics (cGCM), combining physicochemical control with bioinspired functionality.

These engineered cGCM were non-toxic, non-inflammatory, and capable of reducing macrophage uptake by ~10% when incubated with differentiated THP-1 cells. In vitro studies demonstrated significant interaction/ proximity of the cGCM with cancer cells in 2D cultures of breast cancer cells (MDA-MB-231), 3D spheroids of liver (HepG2), and colon (HT-29) cancer cell models, and a zebrafish breast cancer xenograft (MDA-MB-231) model. The cGCM also evaded macrophage detection in a Kdrl:EGFP Spil:Ds Red zebrafish model.

Furthermore, in a pilot assessment, loading and release of the sialyltransferase inhibitor (STI, 3Fax-Peracetyl Neu5Ac) using cGCM significantly reduced α-2,6 sialylation in 2D cultures of MDA-MB-231 cells, demonstrating the STI's intact functionality in inhibiting sialylation. By integrating bioinspired membranes with mechanically tunable gelatin-based carriers, our system demonstrates a multifunctional immune-mimicking platform with relevance to tissue engineering, tumour modelling, immune modulation, and drug delivery.

These findings offer a promising foundation for future therapeutic strategies in cancer research and immuno-engineering.

论文信息

作者
Chugh V、Kanala VK、Quandt D、Kelly S、King D、Jensen LD、Simpson JC、Pandit A
单位
CÚRAM, SFI Research Centre for Medical Devices, University of Galway, Ireland.Ireland
期刊
Journal of tissue engineering2025 Jan-Dec
原文标识
PubMed 41030473 · DOI 10.1177/20417314251349675